Bone Graft Substitutes Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Bone Graft Substitutes Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Bone Graft Substitutes Market

The bone graft substitutes market size was valued at USD 3.81 billion in 2023, and the market is now projected to grow from USD 4.04 billion in 2024 to USD 6.67 billion by 2032, exhibiting a CAGR of 6.5 % during the forecast period of 2024-2032.

The orbit of COVID-19 pandemic is very decisive in the market for bone graft alternatives. Supply Chain disruptions, delays of elective surgeries, and a decrease of hospital resources, reduced demand for bone graft substitutes and, as a result, they shifted focus from the urgent cases to the non-essential ones. The rate of research and development reduced as the focus shifted from managing and understanding COVID-19 and other ailments. Despite this, healthcare innovation has been witnessed in telehealth and remote monitoring and accordingly market growth proved to be gradual, with the development of advanced candidates which are effective for bone graft substitution in a post-pandemic scenario

The bone graft substitutes market growth could be credited both to developments in medical technology and the fact that presently more people experience bone -related disease and injuries than ever before. Innovations such as artificial and biocompatible materials are being produced that stimulate osteo-conduction and osteo-induction processes enhancing the recovery process and integration with human bone. This is propelling the bone graft substitutes market growth.

Additionally, the increasing demand for minimal invasive operation may boost bone graft alternatives consumption. These components lead to the decrement of autografts, and therefore, patients show lesser problems and hospitalize for a shorter period. Already, as professionals in the healthcare setting and patients gain awareness of these advantages, the rise in demand for bone graft substitutes is in progress, hence, future orthopedic treatment is projected to improve.

Comprehensive Analysis of Bone Graft Substitutes Market

Targeting fragmentation is critical in the bone graft substitutes market and helps the manufacturers to tailor products to the particular surgical needs and demographics not only allowing to enhance the market entry but also to achieve superior clinical results. A wide range of bone graft substitutes, like Allograft, Demineralized Bone Matrix (DBM), synthetic products (including Polymer, Ceramic, Hydroxyapatite, and Beta TCP), and Xenografts are very useful as they are suited to diverse types of surgeries and preferences. Its wide area of use for Spinal Fusion, Joint Reconstruction, Foot & Ankle, and more is an explicit proof that a wide range of orthopedic conditions have been taken under consideration with these devices. Components of the market include Hospitals, Specialty Clinics, and other medical care facilities so that companies could develop products and marketing strategy based on facility type and setting preference by general health care.

North America feeds the world bone graft substitutes market share, where there is high level of healthcare network, high healthcare expenditure and advanced medical investigation environment. Besides, the region ascendancy is augmented by the aging community proximity which undergoes orthopedic surgeries and the big market presence of the key industry players who consistently come up with the new inventions in the material sciences and surgical techniques. Furthermore, the regulatory endorsement of fresh and more modern methods assisted by bodies such as the FDA is absolutely necessary for the quick transformation and development of these novel drugs in the North American market.

The top players in the market play a crucial role in shaping the industry's growth trajectory and setting market standards. These players include: Medtronic PLC (Ireland), DePuy Synthes Companies (Johnson & Johnson Services, Inc.) (U.S.), Stryker (U.S.)

In July, 2021, Orthofix Holdings Inc. launched fiberFUSE. In February 2020, GreenBone Ortho, a biomaterials company, secured CE Mark authorization for its bone graft substitute made of rattan wood, known as GreenBone Substitute. To top it off, in the last quarter of 2020 GRAFTYS accomplished recertification of its CE in Europe and obtained the approval of its Quality Management System in accordance with the requirements of Medical Device Single Audit Program (MDSAP) for its sterile calcium phosphate bone graft substitutes in Brazil, Australia and US.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 6.5% from 2024-2032

Unit Value (USD Billion)

Segmentation

By Type

Allograft

Demineralized Bone Matrix (DBM)

Synthetic

- Polymer

- Ceramic

- Hydroxypaptite

- Beta TCP

- Others

Xenograft

By Application

Spinal Fusion

Joint Reconstruction

Foot & Ankle

Others

By End-user

Hospitals

Specialty Clinics

Others

By Geography

North America (By Type, By Application, By End-user, and By Country)

- U.S. (By Application)

- Canada (By Application)

Europe (By Type, By Application, By End-user, and By Country/Sub-region)

- Germany (By Application)

- U.K. (By Application)

- France (By Application)

- Italy (By Application)

- Russia (By Application)

- Rest of Europe (By Application)

Asia Pacific (By Type, By Application, By End-user, and By Country/Sub-region)

- China (By Application)

- India (By Application

- Japan (By Application)

- Australia (By Application)

- Rest of Asia Pacific (By Application)

Latin America (By Type, By Application, By End-user, and By Country/Sub-region)

- Brazil (By Application)

- Mexico (By Application)

- Rest of Latin America (By Application)

Middle East & Africa (By Type, By Application, By End-user, and By Country/Sub-region)

- South Africa (By Application)

- GCC (By Application)

- Rest of Middle East & Africa (By Application)